DESVENLAFAXINE MEDIS desvenlafaxine 50mg modified release tablets blister

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

desvenlafaxine, Quantity: 50 mg

Beschikbaar vanaf:

Medis Pharma Pty Ltd

INN (Algemene Internationale Benaming):

Desvenlafaxine

farmaceutische vorm:

Tablet, modified release

Samenstelling:

Excipient Ingredients: microcrystalline cellulose; citric acid monohydrate; hypromellose; alginic acid; purified talc; magnesium stearate; povidone; titanium dioxide; macrogol 6000; iron oxide red

Toedieningsweg:

Oral

Eenheden in pakket:

28, 14, 7

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

For the treatment of major depressive disorder, including the preventiton of relapse. Not indicated for paediatric use.

Product samenvatting:

Visual Identification: Light pink colored, diamond shaped, biconvex tablets, debossed with 'Ll89' on one side and plain on other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Autorisatie-status:

Licence status A

Autorisatie datum:

2014-11-26